Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC

Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC

SHANGHAI, June 16, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) today announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective small molecule FGFR4...

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

CLEVELAND, June 13, 2025 /PRNewswire/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized controlled trial (RCT). This pivotal study aims to evaluate the...

Kashgar Completes Xinjiang's First 10-GW Photovoltaic Base

Kashgar Completes Xinjiang's First 10-GW Photovoltaic Base

Construction of Southern Xinjiang's New Power System Demonstration Zone Enters New Phase KASHGAR, China, June 11, 2025 /PRNewswire/ -- On May 30, with the full-capacity grid connection of projects like the Huadian Kashgar Jiashi 300 MW Ecological...

Cango Inc. Completes PRC Business Sale, Strengthens Board to Drive Global Bitcoin Focus

Cango Inc. Completes PRC Business Sale, Strengthens Board to Drive Global Bitcoin Focus

SHANGHAI, May 29, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a rapidly expanding leader in Bitcoin mining, has finalized the divestment of all its business in the PRC (the "PRC Business"), a strategic transaction valued...

Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia

Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia

HANGZHOU, China, March 10, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its...

Hankook & Company Group Completes Acquisition of Hanon Systems

Hankook & Company Group Completes Acquisition of Hanon Systems

"Tires, Batteries, Thermal Management": Completing Three Core Portfolios to Become a Global High-Tech Leading Group 10 Years of Investment Culminates in Stable Integration, Synergy Creation, and Financial Structure Improvement Soo Il Lee Appointed...

  • 1
  • 2
  • menu
    menu